ArTS Archivio della ricerca di Trieste

ZORZET, SONIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.308
EU - Europa 4.915
AS - Asia 1.222
AF - Africa 28
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 10
Totale 13.510
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.282
PL - Polonia 1.348
UA - Ucraina 750
SE - Svezia 702
IT - Italia 608
CN - Cina 449
DE - Germania 412
FI - Finlandia 217
SG - Singapore 216
HK - Hong Kong 215
RU - Federazione Russa 185
GB - Regno Unito 181
TR - Turchia 151
FR - Francia 118
IE - Irlanda 115
BG - Bulgaria 114
TW - Taiwan 56
VN - Vietnam 47
BE - Belgio 42
NL - Olanda 35
CH - Svizzera 20
CA - Canada 19
JP - Giappone 19
SN - Senegal 19
IN - India 16
KR - Corea 15
EU - Europa 10
IR - Iran 10
AT - Austria 9
CZ - Repubblica Ceca 9
ES - Italia 8
AU - Australia 7
ID - Indonesia 7
MD - Moldavia 7
PT - Portogallo 7
RO - Romania 6
BR - Brasile 5
CL - Cile 5
MA - Marocco 5
MX - Messico 4
MY - Malesia 4
DK - Danimarca 3
EE - Estonia 3
GR - Grecia 3
HR - Croazia 3
NZ - Nuova Zelanda 3
A1 - Anonimo 2
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BD - Bangladesh 2
CO - Colombia 2
EG - Egitto 2
IL - Israele 2
LB - Libano 2
LT - Lituania 2
LU - Lussemburgo 2
MO - Macao, regione amministrativa speciale della Cina 2
NO - Norvegia 2
PK - Pakistan 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AN - Antille olandesi 1
BY - Bielorussia 1
DM - Dominica 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 13.510
Salva come PNG Salva come JPEG
Città #
Warsaw 1.341
Woodbridge 943
Ann Arbor 887
Fairfield 792
Houston 604
Jacksonville 602
Chandler 579
Wilmington 463
Ashburn 418
Seattle 340
Cambridge 254
Princeton 219
Hong Kong 212
Trieste 178
Singapore 167
Beijing 141
Izmir 128
Sofia 114
Dublin 112
Dearborn 84
Boardman 69
San Diego 59
Taipei 51
Milan 45
Brussels 36
Falls Church 33
Redwood City 28
Saint Petersburg 27
Chicago 26
Düsseldorf 25
Munich 25
Nanjing 23
Hefei 22
Verona 22
Dong Ket 21
Helsinki 21
Moscow 21
Santa Clara 21
Mestre 20
Norwalk 20
Dakar 19
Kocaeli 18
Shanghai 18
Bremen 17
Buffalo 17
Kunming 17
Kyiv 17
Phoenix 17
Bern 13
Des Moines 13
Guangzhou 13
Jinan 13
Washington 11
Buon Ma Thuot 10
Columbus 10
New York 9
Padova 9
Seoul 9
Dagenham 8
Fuzhou 8
Southend 8
Amsterdam 7
Andover 7
Jakarta 7
Nanchang 7
Toronto 7
Cascina 6
Fremont 6
Grafing 6
Hangzhou 6
Ho Chi Minh City 6
Kazan 6
London 6
Los Angeles 6
Sacile 6
Udine 6
Auburn Hills 5
Brno 5
Dallas 5
Frankfurt am Main 5
Langenfeld 5
Modena 5
Palermo 5
Torre Del Greco 5
Vicenza 5
Vienna 5
Wuhan 5
Baotou 4
Chongqing 4
Dongguan 4
Hanoi 4
Kaohsiung City 4
Monfalcone 4
Paris 4
Sarapul 4
Shenyang 4
Sint-Genesius-Rode 4
Sydney 4
Tokyo 4
Torino 4
Totale 9.669
Salva come PNG Salva come JPEG
Nome #
The complement component C3 is expressed by the endometrial ectopic tissue and is involved in the endometriotic lesion formation 688
Effects of Two Fullerene Derivatives on Monocytes and Macrophages 400
C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation 389
Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies 345
The combination of N-acetyl cysteine, alpha-lipoic acid, and bromelain shows high anti-inflammatory properties in novel in vivo and in vitro models of endometriosis 339
Anticancer activity of cationic porphyrins in melanoma tumour-bearing mice and mechanistic in vitro studies 326
Photosensitizing Activity of Pegylated Pheophorbide a 312
Pharmacological activities of ruthenium complexes related to their NO scavenging properties 289
New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles. 227
C1q as a novel player in angiogenesis with therapeutic implication in wound healing 223
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 207
C1q secreted in the tumour microenvironment promotes tumour growth in the absence of complement activation 192
The antimetastatic drug NAMI-A potentiates the phenylephrine-induced contraction of aortic smooth muscle cells and induces a transient increase in systolic blood pressure 176
A novel retinoic/butyric hyaluronan ester for the treatment of acute promyelocytic leukemia: preliminary preclinical results 162
A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles 162
In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab. 160
Chemical, biological and antitumor properties of ruthenium(II) complexes with dimethylsulfoxide 158
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies. 155
Complessi trans di rutenio come agenti antineoplastici 150
Effects of antimetastatic, antiinvasive and cytotoxic agents on the growth and spread of transplantable leukemias in mice. 146
Stress and chemotherapy. Combined effects on tumor progression and immunity in animal models 140
Antitumor properties of ruthenium(II)-dimethylsulfoxide complexes in the Lewis lung carcinoma system 139
Morphological analysis of metastatic potential and antimetastatic drug effects in mice bearing two lines of Lewis lung carcinoma. 138
Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasms 136
Inhibition of B16 Melanoma Metastases with the Ruthenium Complex Imidazolium trans-Imidazoledimethylsulfoxide-tetrachlororuthenate and Down-Regulation of Tumor Cell Invasion. 135
Tumour metastatic potential after treatment with selective antimetastatic drugs 131
Diagnostic and prognostic role of eEF1A in chronic lymphocytic leukaemia 129
null 127
Exploratory study on the effects of biodegradable nanoparticles with drugs on malignant B cells and on a human/mouse model of Burkitt lymphoma. 127
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts. 126
Study of a potential drug delivery system based on carbon nanoparticles: Effects of fullerene derivatives in MCF7 mammary carcinoma cells 126
Cis- and trans-dihalotetrakis(dimethylsulfoxide)Ruthenium(II) Complexes (RuX2(Me2SO)4; X = Cl, Br): Synthesis, Structure and Antitumor Activity 124
Metal complexes of platinum group: the promising antitumor features of cis-dichlorotetrakis(dimethylsulfoxide)Ru(II) (cis- RuCl2(DMSO)4) and related complexes 124
Complessi di Rutenio con elevata attività antitumorale 124
Profiling the molecular mechanism of fullerene cytotoxicity on tumor cells by RNA-seq 124
Effects of NAMI-A and some related ruthenium complexes on cell viability after short exposure of tumor cells. 122
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 119
Antitumour properties of dimethylsulphoxide ruthenium (II) complexes in theLewis lung carcinoma system. 117
Features and full reversibility of the renal toxicity of the ruthenium-based drug NAMI-A in mice 117
null 117
The expression of complement component C3 is specifically localized in endometrial ectopic tissue and is involved in the endometriotic lesion formation 117
Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity. 115
Ruthenium dimeric compounds suitable as antimetastatic and antineoplastic agents 114
Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A 114
Effects of an inducer and an inhibitor of hepatic metabolism on the antitumor action of dimethyltriazenes 113
Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK 111
The PDT activity of free and pegylated pheophorbide a against an amelanotic melanoma transplanted in C57/BL6 mice 111
Reduction of in vivo lung metastases by dinuclear ruthenium complexes is coupled to inhibition of in vitro tumour invasion. 105
Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-But 104
The effect of triamcinolone acetonide, sodium hyaluronate, and chondroitin sulfate on human endothelial cells: an in vitro study 104
Ruthenium complexes with anti-neoplastic agent 104
Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells 104
null 103
In vivo biodistribution and lifetime analysis of cy5.5-conjugated rituximab in mice bearing lymphoid tumor xenograft using time-domain near-infrared optical imaging. 102
DEVELOPMENT OF CHLORAMBUCIL/HYDROXYCHLOROQUINE-LOADED ANTI-CD20 NANOPARTICLES FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA : IN VITRO MODEL 102
Photodynamic Therapy for ras-Driven Cancers: Targeting G-Quadruplex RNA Structures with Bifunctional Alkyl-Modified Porphyrins 102
Effects of two pyridinalalkyliminerhodium(I) complexes in mice bearing MCamammary carcinoma. 101
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds Na2[{trans-RuCl4(Me2SO)}2(μ-L)] (L=ditopic, non-chelating aromatic N-ligand). A preliminary investigation 101
Antineoplastic effects of egg-white lysozyme in mice bearing solid metastasizing tumors 101
Role of host responses in the drug treatment of metastasis 101
Coordination metal complexes of Rh(I), Ir(I) and Ru(II): recent advances on antimetastatic activity on solid mouse tumors 101
Ruthenium complexes with high antitumoral and antimetastatic activities 100
Synthesis and Chemical-Pharmacological Characterization of the Antimetastatic NAMI-A-Type Ru(III) Complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-Dimethyl [1,2,4]triazolo [1,5-a]pyrimidine) 100
Dual action of NAMI-A in inhibition of solid tumor metastasis: Selective targeting of metastatic cells and binding to collagen 100
MAZ-binding G4-decoy with locked nucleic acid and twisted intercalating nucleic acid modifications suppresses KRAS in pancreatic cancer cells and delays tumor growth in mice. 100
Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity 99
PHOTOSENSITIZING ACTIVITY OF PEGYLATED PHEOPHORBIDE a 97
Nitric oxide-mediated activity in anti-cancer photodynamic therapy 96
Activity and inhibition by cytotoxic antimetastatic drugs of cathepsin B-like cysteine proteinases in transplantable leukemias in mice 95
Antineoplastic action of egg-white lysozyme on the growth of MCa mammary carcinoma and TLX5 lymphoma in the CBA mouse. 93
Effects of postsurgical immunotherapy with PGM in mice bearing Lewis lung carcinoma treated with p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt 93
Is effectiveness of cancer chemotherapy influenced by stress? 91
Melatonin administration in tumor-bearing mice (intact and pinealectomized)in relation to stress, zinc, thymulin and IL-2. 90
The Inflammatory Feed-Forward Loop Triggered by the Complement Component C3 as a Potential Target in Endometriosis 90
Therapeutic activity of ICRF-159 combined with surgery: effects of postsurgical treatment with cyclophosphamide in mice bearing Lewis lung carcinoma lines 89
DTIC e i suoi derivati: farmaci citotossici o antimetastatici? 87
Pharmacological effects of the ruthenium complex NAMI-A given orally to CBA mice with MCa mammary carcinoma. 86
Inhibition of human pancreatic cell line MIA PaCa2 proliferation by HA-But, a hyaluronic butyric ester: a preliminary report 86
Conjugated PDT drug. Phptosensitizing activity and tissue distribution of PEGylated pheophorbide a 86
Tumor cell metastasis and surface neutral proteinase: effects of antimetastatic drugs 86
Kinetic investigation of the aqueous stability and antitumor activity of a hydrosoluble diaryltriazene, AVIS, related to the antimetastatic agent DM-COOK 86
Antimetastatic action of orally administered lysozyme in mice bearing Lewis lung arcinoma 84
Tumor cell metastasis and surface neutral proteinase: effects of antimetastatic and antitumor drugs. 84
Seasonal dependency of the effects of rotational stress and cyclophosphamide in mice bearing Lewis lung carcinoma. 83
Potent Apoptotic Response Induced by Chloroacetamidine Anthrathiophenediones in Bladder Cancer Cells. 83
Hyaluronic-acid butyric esters as promising antineoplastic agents in human lung carcinoma: A preclinical study 82
Antineoplastic Activity of planar Rhodium(I) complexes in mice bearing Lewis lung carcinoma and P388 leukemia 82
Effects of chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles on a human/mouse model of Burkitt lymphoma 82
Antineoplastic action of p-(3-methyl-1-triazeno) benzoic acid potassium salt, monomethylderivative of the antimetastatic compound DM-COOK 81
The complement protein C3 is expressed by the endometrial ectopic tissue and is involved in the endometriotic lesion formation 81
Synthesis of *-Alkylmethylen-2-oxo-chromanes with anticoagulant activity and *-Alkylmethylen-*-lactones from 3-Diethylphosphono-3,4-dihydrocoumarins, 3-Diethylphosphonolactones and Aldehydes. Part 2' 78
Increase of tumour infiltrating lymphocytes in mice treated with antimetastatic doses of NAMI-A 78
Intra-tumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and TIL recruitment. 76
Effects of dimethyltriazenes combined with surgery and non-specific immunotherapy in mice bearin Lewis lung carcinoma lines 76
Primary tumor growth and formation of spontaneous lung metastases in mice bearing Lewis lung carcinoma treated with proteinase inhibitors 75
Synthesis and structure-activity relationships of α-alkylmethylen-2-oxo-chromanes with anticoagulant activity 72
The Chlorophyll Catabolite Pheophorbide a as a Photosensitizer for thePhotodynamic Therapy 70
Infiltration of liver and brain by tumor cells in leukemik mice: prevention by dimethyltriazenes and cyclophosphamide. 69
Tumour cell uptake, G2-M accumulation and cytotoxicity of NAMI-A on TS/A adenocarcinoma cells 64
Lack of in vitro cytotoxicity, associated to increased G2-M cell fraction and inhibition of matrigel invasion, may predict in vivo-selective antimetastasis activity of ruthenium complexes 59
Totale 13.287
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.190
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.309 0 0 0 452 191 357 282 306 249 184 214 74
2020/20211.932 183 86 164 231 133 240 155 177 127 197 80 159
2021/20221.585 67 111 90 179 25 124 57 106 214 149 81 382
2022/20231.814 180 233 142 237 187 311 25 164 214 24 69 28
2023/2024983 72 61 81 60 111 76 134 203 15 37 69 64
2024/2025321 43 62 165 51 0 0 0 0 0 0 0 0
Totale 13.932